Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a 3.421\% human ether-à-go-go related gene (hERG) inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a O=C(NC1CCCCC1)C(c1ccncc1)N(Cc1ccc2c(c1)OCO2)C(=O)C(F)(F)F
b CC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)NC1CCCCC1
c COC(=O)C(CCSC)NC(=O)CNS(=O)(=O)c1ccc(Br)cc1
Answer: b. CC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)NC1CCCCC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)NC1CCCCC1
CC(Sc1nnc2c(n1)[nH]c1ccccc12)C(=O)NC1CCCCC1
N-cyclohexyl-2-(5H-[1,2,4]triazino[5,6-b]indol-3-ylsulfanyl)propanamide